apelin receptor early endogenous ligand



apelin receptor early endogenous ligand

Q1QQ1R2RR2P3PP3V4VV4N5NN5L6LL6T7TT7M8MM8R9RR9R10RR10K11KK11L12LL12R13RR13K14KK14H15HH15N16NN16C17CC17L18LL18Q19QQ19R20RR20R21RR21C22CC22M23MM23P24PP24L25LL25H26HH26S27SS27R28RR28V29VV29P30PP30F31FF31P32PP32

SMILES None
InChIKey None
Sequence QRPVNLTMRRKLRKHNCLQRRCMPLHSRVPFP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

apelin receptor early endogenous ligand

Q1QQ1R2RR2P3PP3V4VV4N5NN5L6LL6T7TT7M8MM8R9RR9R10RR10K11KK11L12LL12R13RR13K14KK14H15HH15N16NN16C17CC17L18LL18Q19QQ19R20RR20R21RR21C22CC22M23MM23P24PP24L25LL25H26HH26S27SS27R28RR28V29VV29P30PP30F31FF31P32PP32

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.